BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33825035)

  • 1. Use of cucurbitacins for lung cancer research and therapy.
    Liu M; Yan Q; Peng B; Cai Y; Zeng S; Xu Z; Yan Y; Gong Z
    Cancer Chemother Pharmacol; 2021 Jul; 88(1):1-14. PubMed ID: 33825035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
    Cai Y; Fang X; He C; Li P; Xiao F; Wang Y; Chen M
    Am J Chin Med; 2015; 43(7):1331-50. PubMed ID: 26503558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds.
    Ríos JL; Andújar I; Escandell JM; Giner RM; Recio MC
    Curr Pharm Des; 2012; 18(12):1663-76. PubMed ID: 22443631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytotoxic effects of natural and semisynthetic cucurbitacins on lung cancer cell line A549.
    Silva IT; Geller FC; Persich L; Dudek SE; Lang KL; Caro MS; Durán FJ; Schenkel EP; Ludwig S; Simões CM
    Invest New Drugs; 2016 Apr; 34(2):139-48. PubMed ID: 26780083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
    Chen X; Bao J; Guo J; Ding Q; Lu J; Huang M; Wang Y
    Anticancer Drugs; 2012 Sep; 23(8):777-87. PubMed ID: 22561419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ANTITUMOR AND APOPTOTIC EFFECTS OF CUCURBITACIN A IN A-549 LUNG CARCINOMA CELLS IS MEDIATED VIA G2/M CELL CYCLE ARREST AND M-TOR/PI3K/AKT SIGNALLING PATHWAY.
    Wang WD; Liu Y; Su Y; Xiong XZ; Shang D; Xu JJ; Liu HJ
    Afr J Tradit Complement Altern Med; 2017; 14(2):75-82. PubMed ID: 28573224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential of cucurbitacin as an anticancer drug.
    Li Y; Li Y; Yao Y; Li H; Gao C; Sun C; Zhuang J
    Biomed Pharmacother; 2023 Dec; 168():115707. PubMed ID: 37862969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cucurbitacins as Anticancer Agents: A Patent Review.
    Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
    Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
    Tuli HS; Rath P; Chauhan A; Ranjan A; Ramniwas S; Sak K; Aggarwal D; Kumar M; Dhama K; Lee EHC; Yap KC; Capinpin SM; Kumar AP
    Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671442
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cucurbitacin mediated regulation of deregulated oncogenic signaling cascades and non-coding RNAs in different cancers: Spotlight on JAK/STAT, Wnt/β-catenin, mTOR, TRAIL-mediated pathways.
    Lin X; Farooqi AA
    Semin Cancer Biol; 2021 Aug; 73():302-309. PubMed ID: 33152487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms.
    Varela C; Melim C; Neves BG; Sharifi-Rad J; Calina D; Mamurova A; Cabral C
    J Transl Med; 2022 Dec; 20(1):630. PubMed ID: 36585670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cucurbitacins in the treatment of hepatitis and primary liver cancer. Current status of pharmacological and clinical research].
    Ren FB; Hong M
    Zhong Xi Yi Jie He Za Zhi; 1986 Oct; 6(10):633-5. PubMed ID: 2949871
    [No Abstract]   [Full Text] [Related]  

  • 13. Actin-aggregating cucurbitacins from Physocarpus capitatus.
    Maloney KN; Fujita M; Eggert US; Schroeder FC; Field CM; Mitchison TJ; Clardy J
    J Nat Prod; 2008 Nov; 71(11):1927-9. PubMed ID: 18959442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cucurbitacin: ancient compound shedding new light on cancer treatment.
    Lee DH; Iwanski GB; Thoennissen NH
    ScientificWorldJournal; 2010 Mar; 10():413-8. PubMed ID: 20209387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect of traditional Chinese herbal medicines against lung cancer.
    Chen Y; Zhu J; Zhang W
    Anticancer Drugs; 2014 Oct; 25(9):983-91. PubMed ID: 24892722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory Mechanisms.
    Silvestre GFG; de Lucena RP; da Silva Alves H
    Curr Med Chem; 2022; 29(21):3774-3789. PubMed ID: 34994307
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolation of anticancer constituents from Cucumis prophetarum var. prophetarum through bioassay-guided fractionation.
    Alsayari A; Kopel L; Ahmed MS; Soliman HSM; Annadurai S; Halaweish FT
    BMC Complement Altern Med; 2018 Oct; 18(1):274. PubMed ID: 30301463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
    Kumar A; Sharma B; Sharma U; Parashar G; Parashar NC; Rani I; Ramniwas S; Kaur S; Haque S; Tuli HS
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1867-1878. PubMed ID: 37010571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulforaphane: Expected to Become a Novel Antitumor Compound.
    Wu G; Yan Y; Zhou Y; Duan Y; Zeng S; Wang X; Lin W; Ou C; Zhou J; Xu Z
    Oncol Res; 2020 Sep; 28(4):439-446. PubMed ID: 32111265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cucurbitacins from the Leaves of Citrullus colocynthis (L.) Schrad.
    Chawech R; Jarraya R; Girardi C; Vansteelandt M; Marti G; Nasri I; Racaud-Sultan C; Fabre N
    Molecules; 2015 Sep; 20(10):18001-15. PubMed ID: 26437392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.